DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA

Department of Health and Human Services

Award: Department of Health and Human ServicesNAICS n/aSAM# 75A50125C00017

Posted 2026-07-19 · Response deadline 2027-09-29 · Set-aside: None

Recipient: CIDARA THERAPEUTICS INC | $58051983.0

View official SAM.gov notice →

← All opportunities